Group 1 - The core point of the article highlights that Chengyitong's stock price dropped by 5.28% to 24.24 CNY per share, with a trading volume of 174 million CNY and a turnover rate of 2.69%, resulting in a total market capitalization of 6.619 billion CNY [1] - Chengyitong, established on July 22, 2003, and listed on March 19, 2015, specializes in providing overall solutions for pharmaceutical and biopharmaceutical automation control systems, as well as the research, production, and sales of rehabilitation medical devices [1] - The revenue composition of Chengyitong includes 54.65% from control systems, 28.89% from rehabilitation medical devices, and 16.47% from system equipment and others [1] Group 2 - Longcheng Fund's Longcheng Consumption Value Mixed A (200006) fund is among the top ten circulating shareholders of Chengyitong, holding 2 million shares, which accounts for 0.77% of the circulating shares, with an estimated floating loss of approximately 2.7 million CNY [2] - The Longcheng Consumption Value Mixed A fund was established on April 6, 2006, with a latest scale of 516 million CNY, achieving a year-to-date return of 21.73% and a one-year return of 44.1% [2] - The fund manager, Long Yufei, has been in position for 8 years and 93 days, with the fund's total asset scale at 780 million CNY, achieving a best return of 61.42% and a worst return of -8.9% during his tenure [3] Group 3 - Longcheng Consumption Value Mixed A (200006) fund has Chengyitong as its ninth largest heavy stock, holding 2 million shares, which represents 4.74% of the fund's net value, with an estimated floating loss of around 2.7 million CNY [4]